|
EPB41L4B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.79252226582139E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.40081304731166E-12 |
| Normal-vs-Stage2 |
2.54340992711377E-12 |
| Normal-vs-Stage3 |
1.94550042742492E-10 |
| Normal-vs-Stage4 |
1.006070E-04 |
| Stage1-vs-Stage2 |
3.960600E-01 |
| Stage1-vs-Stage3 |
4.720100E-02 |
| Stage1-vs-Stage4 |
2.002600E-01 |
| Stage2-vs-Stage3 |
1.293600E-02 |
| Stage2-vs-Stage4 |
1.359950E-01 |
| Stage3-vs-Stage4 |
6.505200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.11528580709819E-12 |
| Normal-vs-AfricanAmerican |
4.80060435847918E-13 |
| Normal-vs-Asian |
4.303200E-03 |
| Caucasian-vs-AfricanAmerican |
1.806980E-01 |
| Caucasian-vs-Asian |
3.299900E-02 |
| AfricanAmerican-vs-Asian |
2.738000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.80733206178729E-12 |
| Normal-vs-Female |
1.63602464908763E-12 |
| Male-vs-Female |
5.755200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.61459734471237E-11 |
| Normal-vs-Extreme_Weight |
1.6242562850266E-12 |
| Normal-vs-Obese |
1.00319752505129E-11 |
| Normal-vs-Extreme_Obese |
3.010000E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.036600E-01 |
| Normal_Weight-vs-Obese |
8.214000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.712000E-01 |
| Extreme_Weight-vs-Obese |
9.707800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.605200E-01 |
| Obese-vs-Extreme_Obese |
7.254400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.82677999999159E-05 |
| Normal-vs-Age(41-60Yrs) |
5.17530462929017E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.13373763102709E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.153600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.540500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.599200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.199400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.422270E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.321900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.34392497130875E-12 |
| Normal-VS-Type2 PRCC |
1.02540198554379E-11 |
| Normal-VS-KIRP CIMP |
6.070400E-02 |
| Normal-VS-Unclassified PRCC |
4.32731628308147E-12 |
| Type1 PRCC-VS-Type2 PRCC |
4.817300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.575700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
9.563600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.85139999997475E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
5.717000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.93420000033684E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.96824803519758E-12 |
| Normal-vs-N1 |
1.22819999726076E-08 |
| Normal-vs-N2 |
2.188400E-02 |
| N0-vs-N1 |
5.760900E-03 |
| N0-vs-N2 |
4.725400E-01 |
| N1-vs-N2 |
8.581000E-01 |
|
|
